Herbal Therapeutics that Block the Oncogenic Kinase PAK1: A Practical Approach towards PAK1-dependent Diseases and Longevity
- 14 August 2013
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 28 (5) , 656-672
Abstract
Over 35 years research on PAKs, RAC/CDC42(p21)‐activated kinases, comes of age, and in particular PAK1 has been well known to be responsible for a variety of diseases such as cancer (mainly solid tumors), Alzheimer's disease, acquired immune deficiency syndrome and other viral/bacterial infections, inflammatory diseases (asthma and arthritis), diabetes (type 2), neurofibromatosis, tuberous sclerosis, epilepsy, depression, schizophrenia, learning disability, autism, etc. Although several distinct synthetic PAK1‐blockers have been recently developed, no FDA‐approved PAK1 blockers are available on the market as yet. Thus, patients suffering from these PAK1‐dependent diseases have to rely on solely a variety of herbal therapeutics such as propolis and curcumin that block PAK1 without affecting normal cell growth. Furthermore, several recent studies revealed that some of these herbal therapeutics significantly extend the lifespan of nematodes (C. elegans) and fruit flies (Drosophila), and PAK1‐deficient worm lives longer than the wild type. Here, I outline mainly pathological phenotypes of hyper‐activated PAK1 and a list of herbal therapeutics that block PAK1, but cause no side (harmful) effect on healthy people or animals. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 132 references indexed in Scilit:
- Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial MemoryJournal of Cerebral Blood Flow & Metabolism, 2011
- Curcumin-mediated lifespan extension in Caenorhabditis elegansMechanisms of Ageing and Development, 2011
- Disrupted-in-Schizophrenia 1–mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signalingProceedings of the National Academy of Sciences, 2011
- AMP-Activated Protein Kinase and Metabolic Control2011
- Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1‐mediated COX‐2 expressionInternational Journal of Cancer, 2010
- Quassinoid Inhibition of AP-1 Function Does Not Correlate with Cytotoxicity or Protein Synthesis InhibitionJournal of Natural Products, 2009
- Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in miceProceedings of the National Academy of Sciences, 2007
- Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in ratsPharmacology Biochemistry and Behavior, 2005
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003
- The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1British Journal of Cancer, 2002